Please assess the completion status of the following clinical trial:

Trial Title: A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~The participants have to meet all of the following criteria to be eligible to enter the study:~* Willing and able to provide informed consent~* Male or female and aged 18 years or above~* Volunteers able to read and understand English~* A personal history of atopic dermatitis~Exclusion Criteria:~Participants meeting any of the following criteria will not be permitted to enter the study:~* Eczema on the volar forearms requiring anti-inflammatory treatment~* Possible allergy to ingredients in the study medications.~* Any serious current medical condition which, in the opinion of the Investigator, may interfere with the evaluation of the results or may be contraindicated by the use of the test medications~* Use of any concomitant medication that may interfere with the study related activities or assessment of efficacy, as judged by the Investigator~* Use of any topical product, including cosmetic leave-on products on the volar forearms, within 1 week prior to, and throughout the study~* Female participant who, according to the participant, is pregnant or breast-feeding, or plans to become pregnant during the course of the study~* Any participant-related factor suggesting potential poor compliance with study procedures (e.g. psychiatric disorders, history of alcohol or substance abuse), as judged by the Investigator~* Enrolment in any interventional study or use of an investigational drug within 3 months prior to the screening visit~* Volunteers judged by the PI to be inappropriate for the trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Test cream (2% urea/20% glycerol) (Type: EXPERIMENTAL): Topical cream, 1 Finger Tip Unit per treatment area on the lower volar forearms twice daily for 28 days
- Reference cream 1: Miniderm® 20% cream (20% glycerol) (Type: ACTIVE_COMPARATOR): Topical cream, 1 Finger Tip Unit per treatment area on the lower volar forearms twice daily for 28 days
- Reference cream 2: Diprobase® cream (cream without humectants) (Type: ACTIVE_COMPARATOR): Topical cream, 1 Finger Tip Unit per treatment area on the lower volar forearms twice daily for 28 days
- Untreated (Type: NO_INTERVENTION): Untreated skin area on the volar forearm

Based on this trial design, predict the completion outcome and termination type (if applicable).